Pharmaceutical manufacturing handbook: production and processes / [edited by] Shayne Cox Gad.
Material type: TextPublication details: Hoboken, N.J. : Wiley, 2008.Description: xiii, 1370 p.; ill.; 26cmISBN:- 0470259582
- 9780470259580
- 615.19 GAD
Item type | Current library | Call number | Copy number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|
Standard Loan | Moylish Library Main Collection | 615.19 GAD (Browse shelf(Opens below)) | 1 | Available | 39002100331686 | ||
Standard Loan | Moylish Library Main Collection | 615.19 GAD (Browse shelf(Opens below)) | 2 | Available | 39002100474890 |
Browsing Moylish Library shelves, Shelving location: Main Collection Close shelf browser (Hides shelf browser)
Enhanced descriptions from Syndetics:
This handbook features contributions from a team of expert authors representing the many disciplines within science, engineering, and technology that are involved in pharmaceutical manufacturing. They provide the information and tools you need to design, implement, operate, and troubleshoot a pharmaceutical manufacturing system. The editor, with more than thirty years' experience working with pharmaceutical and biotechnology companies, carefully reviewed all the chapters to ensure that each one is thorough, accurate, and clear.
Includes bibliographical references and index.
Table of contents provided by Syndetics
- Contributors
- Preface
- Section 1 Manufacturing Specialties
- 1.1 Biotechnology-Derived Drug Product Development
- 1.2 Regulatory Considerations in Approval on Follow-On Protein Drug Products
- 1.3 Radiopharmaceutical Manufacturing
- Ivfn Pe_uelas
- Section 2 Aseptic Processing
- 2.1 Sterile Product Manufacturing
- Section 3 Facility
- 3.1 From Pilot Plant to Manufacturing: Effect of Scale-Up on Operation of Jacketed Reactors
- 3.2 Packaging and Labeling
- 3.3 Clean-Facility Design, Construction, and Maintenance Issues
- Section 4 Normal Dosage Forms
- 4.1 Solid Dosage Forms
- 4.2 Semisolid Dosages: Ointments, Creams, and Gels
- 4.3 Liquid Dosage Forms
- Section 5 New Dosage Forms
- 5.1 Controlled-Release Dosage Forms
- 5.2 Progress in the Design of Biodegradable Polymer-Based Microspheres for Parenteral Controlled Delivery of Therapeutic Peptide/Protein
- 5.3 Liposomes and Drug Delivery
- 5.4 Biodegradable Nanoparticles
- 5.5 Recombinant Saccharomyces cerevisiae as New Drug Delivery System to Gut: In Vitro Validation and Oral Formulation
- 5.6 Nasal Delivery of Peptide and Nonpeptide Drugs
- 5.7 Nasal Powder Drug Delivery
- 5.8 Aerosol Drug Delivery
- 5.9 Ocular Drug Delivery
- 5.10 Microemulsions as Drug Delivery Systems
- 5.11 Transdermal Drug Delivery
- 5.12 Vaginal Drug Delivery
- Section 6 Tablet Production
- 6.1 Pharmaceutical Preformulation: Physicochemical Properties of Excipients and Powers and Tablet Characterization
- 6.2 Role of Preformulation in Discovery and Development: Pharmaceutics of Solid Dosage Forms
- 6.3 Tablet Design
- 6.4 Tablet Production Systems
- 6.5 Controlled Release of Drugs from Tablet Coatings
- 6.6 Tablet Compression
- 6.7 Effects of Grinding in Pharmaceutical Tablet Production
- 6.8 Oral Extended-Release Formulations
- Section 7 Role Of Nanotechnology
- 7.1 Cyclodextrin-Based Nanomaterials in Pharmaceutical Field
- 7.2 Nanotechnology in Pharmaceutical Manufacturing
- 7.3 Pharmaceutical Nanosystems: Manufacture, Characterization, and Safety
- 7.4 Oil-in-Water Nanosized Emulsions: Med